Exelixis Business Operations Contracts & Agreements

80 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Fifth Amendment to Collaboration and License Agreement between Exelixis, Inc. and Ipsen Pharma SAS
Collaboration Agreements
Exelixis
Biotechnology
2023
Fourth Amendment to Collaboration and License Agreement between Exelixis, Inc. and Ipsen Pharma SAS
Collaboration Agreements
Exelixis
Biotechnology
2023
Second Amendment to Collaboration and License Agreement between Exelixis, Inc. and Takeda Pharmaceutical Company Limited
Collaboration Agreements
Exelixis
Biotechnology
2022
Third Amendment to Supply Agreement between Exelixis, Inc. and Ipsen Pharma SAS
Supply Agreements
Exelixis
Biotechnology
2022
Exelixis, Inc. Indemnification Agreement with Director or Officer
Indemnification Agreements
Exelixis
Biotechnology
DE
2022
First Amendment to Supply Agreement between Exelixis, Inc. and Ipsen Pharma SAS (October 26, 2017)
Supply Agreements
Exelixis
Biotechnology
2021
Supply Agreement between Exelixis, Inc. and IPSEN Pharma SAS for Cabozantinib
Supply Agreements
Exelixis
Biotechnology
NY
2021
Third Amendment to Collaboration and License Agreement between Exelixis, Inc. and Ipsen Pharma SAS
Collaboration Agreements
Exelixis
Biotechnology
2021
Second Amendment to Collaboration and License Agreement between Exelixis, Inc. and Ipsen Pharma SAS
Collaboration Agreements
Exelixis
Biotechnology
2021
First Amendment to Collaboration and License Agreement between Exelixis, Inc. and Ipsen Pharma SAS
Collaboration Agreements
Exelixis
Biotechnology
2021
Third Amendment to Collaboration and License Agreement between Exelixis, Inc. and Takeda Pharmaceutical Company Limited
Collaboration Agreements
Exelixis
Biotechnology
2020
Amendment No. 2 to the Ipsen Supplement Agreement among Exelixis, Inc., Bristol-Myers Squibb Company, and Ipsen Pharma SAS
Collaboration Agreements
Exelixis
Biotechnology
2020
Supplement to Joint Clinical Research Agreement among Exelixis, Roche, and Ipsen (December 18, 2019)
Collaboration Agreements
Exelixis
Biotechnology
CA
2020
Joint Clinical Research Agreement between Exelixis, Inc. and F. Hoffmann-La Roche Ltd (December 18, 2019)
Collaboration Agreements
Exelixis
Biotechnology
CA
2020
Second Amendment to Collaboration and License Agreement between Exelixis, Inc. and Takeda Pharmaceutical Company Limited
Collaboration Agreements
Exelixis
Biotechnology
2019
Second Amendment to Supply Agreement between Exelixis, Inc. and Ipsen Pharma SAS
Supply Agreements
Exelixis
Biotechnology
2019
Amendment No. 3 to Cooperative Research and Development Agreement Between Exelixis Inc. and National Cancer Institute for Cabozantinib Clinical Development
Collaboration Agreements
Exelixis
Biotechnology
2019
Ono Territory Supplemental Agreement among Ono Pharmaceutical, Bristol-Myers Squibb, and Exelixis (July 6, 2018)
Collaboration Agreements
Exelixis
Biotechnology
NY
2018
Supplement to Clinical Trial Collaboration Agreement among Exelixis, Inc., Bristol-Myers Squibb Company, and Takeda Pharmaceutical Company Limited
Collaboration Agreements
Exelixis
Biotechnology
NY
2018
Amendment to Ipsen Supplement Agreement to Clinical Trial Collaboration Agreement among Exelixis, Inc., Bristol-Myers Squibb Company, and Ipsen Pharma SAS
Collaboration Agreements
Exelixis
Biotechnology
2018
First Amendment to Collaboration and License Agreement between Exelixis, Inc. and Takeda Pharmaceutical Company Limited
Collaboration Agreements
Exelixis
Biotechnology
2018
First Amendment to Supply Agreement between Exelixis, Inc. and Ipsen Pharma SAS (October 26, 2017)
Supply Agreements
Exelixis
Biotechnology
2018
Third Amendment to Collaboration and License Agreement between Exelixis, Inc. and Ipsen Pharma SAS
Collaboration Agreements
Exelixis
Biotechnology
2018
Second Amendment to Collaboration and License Agreement between Exelixis, Inc. and Ipsen Pharma SAS
Collaboration Agreements
Exelixis
Biotechnology
2017
Third Amendment to Collaboration Agreement between Exelixis, Inc. and Genentech, Inc.
Collaboration Agreements
Exelixis
Biotechnology
2017
Supplement to Clinical Trial Collaboration Agreement among Exelixis, Bristol-Myers Squibb, and Ipsen Pharma SAS (February 24, 2017)
Collaboration Agreements
Exelixis
Biotechnology
NY
2017
Clinical Trial Collaboration Agreement between Exelixis, Inc. and Bristol-Myers Squibb Company
Collaboration Agreements
Exelixis
Biotechnology
NY
2017
First Amendment to Collaboration Agreement between Exelixis, Inc. and Genentech, Inc.
Collaboration Agreements
Exelixis
Biotechnology
2017
Collaboration Agreement between Exelixis, Inc. and Genentech, Inc. (December 22, 2006)
Collaboration Agreements
Exelixis
Biotechnology
CA
2017
First Amendment to Collaboration and License Agreement between Exelixis, Inc. and Ipsen Pharma SAS
Collaboration Agreements
Exelixis
Biotechnology
2017
Amendment No. 2 to Cooperative Research and Development Agreement Between Exelixis Inc. and National Cancer Institute
Collaboration Agreements
Exelixis
Biotechnology
2017
Amendment No. 1 to Cooperative Research and Development Agreement (CRADA) between Exelixis Inc. and National Cancer Institute for Cabozantinib Clinical Development
Collaboration Agreements
Exelixis
Biotechnology
2017
Cooperative Research and Development Agreement for Clinical Research between National Cancer Institute and Exelixis, Inc.
Collaboration Agreements
Exelixis
Biotechnology
DC
2017
Amended and Restated Collaboration Agreement between Exelixis, Inc., Exelixis Patent Company, LLC, and Bristol-Myers Squibb Company
Collaboration Agreements
Exelixis
Biotechnology
DE
2016
Supply Agreement between Exelixis, Inc. and Ipsen Pharma SAS for Cabozantinib
Supply Agreements
Exelixis
Biotechnology
NY
2016
Partial Lease Termination Agreement between Britannia Pointe Grand Limited Partnership and Exelixis, Inc. (June 30, 2015)
Termination Agreements
Exelixis
Biotechnology
DE
2015
Collaboration Agreement between Exelixis, Inc. and Sanofi-Aventis dated May 27, 2009
Collaboration Agreements
Exelixis
Biotechnology
NY
2014
Product Development and Commercialization Agreement between SmithKline Beecham Corporation (GlaxoSmithKline) and Exelixis, Inc. dated October 28, 2002
Collaboration Agreements
Exelixis
Biotechnology
NY
2013
Side Letter Agreement Regarding Shared Services Costs under Sublease between Exelixis, Inc. and Nodality, Inc.
Services Agreements
Exelixis
Biotechnology
2012
Termination Agreement between Exelixis, Inc. and GlaxoSmithKline, LLC (Foretinib Product Development)
Termination Agreements
Exelixis
Biotechnology
NY
2015